المؤلفون: Aygen, Bilgehan, Demirtürk, Neşe, Yıldız, Orhan, Çelen, Mustafa Kemal, Çelik, İlhami, Barut, Şener, Ural, Onur, Batırel, Ayşe, Şimşek, Funda, Aşan, Ali, Ersöz, Gülden, Türker, Nesrin, Bilgin, Hüseyin, Kınıklı, Sami, Karakeçili, Faruk, Zararsız, Gökmen

المساهمون: Bursa Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı., Mıstık, Reşit, DFY-3761-2022, 6602564624

مصطلحات موضوعية: Gastroenterology & hepatology, Chronic hepatitis c, Hcv genotypes 1 and 4, Ombitasvir, Paritaprevir, Dasabuvir, Real-world effectiveness, Sustained virological response, Ritonavir plus ribavirin, Antiviral therapy, Hcv, Abt-450/r-ombitasvir, Multicenter, Paritaprevir/ritonavir/ombitasvir, Retreatment, 2-Naphthylamine, Adult, Aged, 80 and over, Anilides, Antiviral agents, Cyclopropanes, Databases, Factual, Drug therapy, combination, Female, Genotype, Hepacivirus, Hepatitis C

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; Turkish Journal of Gastroenterology; Yurt içi; Sanayi; Aygen, B. vd. (2020). "Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience". Turkish Journal of Gastroenterology, 31(4), 305-317.; https://turkjgastroenterol.org/en/real-world-efficacy-safety-and-clinical-outcomes-of-ombitasvir-paritaprevir-ritonavir-dasabuvir-ribavirin-combination-therapy-in-patients-with-hepatitis-c-virusTest-genotype-1-or-4-infection-the-turkey-experience-experience-136659; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236650Test/; https://hdl.handle.net/11452/38946Test; 000535263200004; 2-s2.0-85084787334; 305; 317; 31; https://doi.org/10.5152/tjg.2020.19197Test

الإتاحة: https://doi.org/10.5152/tjg.2020.19197Test
https://hdl.handle.net/11452/38946Test
https://turkjgastroenterol.org/en/real-world-efficacy-safety-and-clinical-outcomes-of-ombitasvir-paritaprevir-ritonavir-dasabuvir-ribavirin-combination-therapy-in-patients-with-hepatitis-c-virusTest-genotype-1-or-4-infection-the-turkey-experience-experience-136659
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236650Test/

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı., Mıstık, Reşit, 6602564624

مصطلحات موضوعية: Infectious diseases, Baseline resistance, Hepatitis C virus, Mutation, Protease inhibitors, Genotype 1, Pegylated interferon, Antiviral agents, Virus genotypes, Ribavirin, Telaprevir, Simeprevir, Infection, Polymorphisms, Retreatment, Adult, Aged, 80 and over, Drug resistance, viral, Female, Genotype, Hepacivirus, Hepatitis C, chronic, Humans, Male, Middle aged, Oligopeptides, Proline

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; International Journal of Infectious Diseases; Yurt içi; Yurt dışı; Sanayi; Altunok, E. S. vd. (2016). "Protease inhibitors drug resistance mutations in Turkish patients with chronic hepatitis C". ed. Petersen, E. ve Denmark, A. International Journal of Infectious Diseases, 50, 1-5.; https://doi.org/10.1016/j.ijid.2016.07.003Test; https://www.sciencedirect.com/science/article/pii/S1201971216311109Test; http://hdl.handle.net/11452/29837Test; 000388326300001; 2-s2.0-84979254596; 50

الإتاحة: https://doi.org/10.1016/j.ijid.2016.07.003Test
http://hdl.handle.net/11452/29837Test
https://www.sciencedirect.com/science/article/pii/S1201971216311109Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Anabilim Dalı., Mıstık, Reşit, 6602564624

مصطلحات موضوعية: Infectious diseases, Baseline resistance, Hepatitis C virus, Mutation, Protease inhibitors, Genotype 1, Pegylated interferon, Antiviral agents, Virus genotypes, Ribavirin, Telaprevir, Simeprevir, Infection, Polymorphisms, Retreatment, Adult, Aged, 80 and over, Drug resistance, viral, Female, Genotype, Hepacivirus, Hepatitis C, chronic, Humans, Male, Middle aged, Oligopeptides, Proline

وصف الملف: application/pdf

العلاقة: Makale - Uluslararası Hakemli Dergi; International Journal of Infectious Diseases; Yurt içi; Yurt dışı; Sanayi; Altunok, E. S. vd. (2016). "Protease inhibitors drug resistance mutations in Turkish patients with chronic hepatitis C". ed. Petersen, E. ve Denmark, A. International Journal of Infectious Diseases, 50, 1-5.; https://doi.org/10.1016/j.ijid.2016.07.003Test; https://www.sciencedirect.com/science/article/pii/S1201971216311109Test; http://hdl.handle.net/11452/29837Test; 000388326300001; 2-s2.0-84979254596; 50

الإتاحة: https://doi.org/10.1016/j.ijid.2016.07.003Test
http://hdl.handle.net/11452/29837Test
https://www.sciencedirect.com/science/article/pii/S1201971216311109Test